It has been reported that ABCG2 plays multifunctional roles in human diseases, such as inducing multidrug resistance in cancer treatment, contributing to the risk for hyperuricemia and gout, and overexpressing in resistant acute myeloid leukemia phenotype [23,24,25,26,27,28]. This evidence concerns the gene ABCG2 and acute myeloid leukemia.